Zobrazeno 1 - 10 of 48 pro vyhledávání: '"Toh TB"'
1
Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas
Autor: Ding, X, Mohd Abdul Rashid, MB, Toh, TB, Silva, A, Nurrul Abdullah, L, Ho, CM, Ho, D, Chow, EKH
Publikováno v: Ding, X; Mohd Abdul Rashid, MB; Toh, TB; Silva, A; Nurrul Abdullah, L; Ho, CM; et al.(2015). Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas. Journal of Laboratory Automation, 20(4), 423-437. doi: 10.1177/2211068215579612. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1tv1004x
© 2015, © 2015 Society for Laboratory Automation and Screening. Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. The expression of glucose transporter isoform 1, a key factor in transporting glucose into cancer cells, is ov
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::38a94bada75163d304211ad92eb5727d
http://www.escholarship.org/uc/item/1tv1004x
Zobrazit plný text záznamu
2
Author Correction: METTL8 links mt-tRNA m 3 C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity.
Autor: Lee BWL; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Chuah YH; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Yoon J; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Grinchuk OV; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Liang Y; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore., Hirpara JL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Shen Y; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Wang LC; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Lim YT; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Zhao T; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Sobota RM; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Yeo TT; Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore., Wong ALA; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Teo K; Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore., Nga VDW; Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore., Tan BWQ; Department of Medicine, National University Hospital, Singapore, Singapore., Suda T; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, 860-0811, Japan., Toh TB; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Pervaiz S; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lin Z; Department of Biological Sciences, 14 Science Drive 4, National University of Singapore, 117543, Singapore, Singapore., Ong DST; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore. phsostd@nus.edu.sg.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. phsostd@nus.edu.sg.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. phsostd@nus.edu.sg.; National Neuroscience Institute, 308433, Singapore, Singapore. phsostd@nus.edu.sg.
Publikováno v: Cell death & disease [Cell Death Dis] 2024 Jul 31; Vol. 15 (7), pp. 547. Date of Electronic Publication: 2024 Jul 31.
Zobrazit plný text záznamu
3
Akademický článek
Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.
Autor: Toh TB; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Thng DKH; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Bolem N; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Vellayappan BA; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore., Tan BWQ; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Shen Y; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Soon SY; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Ang YLE; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Dinesh N; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Teo K; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Nga VDW; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Low SW; Division of Neurological Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Khong PL; Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore.; Clinical Imaging Research Centre (CIRC), National University of Singapore, Singapore, Singapore., Chow EK; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Ho D; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Yeo TT; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Wong ALA; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore.
Publikováno v: PloS one [PLoS One] 2024 Jul 26; Vol. 19 (7), pp. e0307818. Date of Electronic Publication: 2024 Jul 26 (Print Publication: 2024).
Zobrazit plný text záznamu
4
Akademický článek
METTL8 links mt-tRNA m 3 C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity.
Autor: Lee BWL; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Chuah YH; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Yoon J; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Grinchuk OV; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Liang Y; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore., Hirpara JL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Shen Y; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Wang LC; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Lim YT; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Zhao T; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Sobota RM; Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Yeo TT; Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore., Wong ALA; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Teo K; Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore., Nga VDW; Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore., Tan BWQ; Department of Medicine, National University Hospital, Singapore, Singapore., Suda T; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, 860-0811, Japan., Toh TB; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Pervaiz S; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lin Z; Department of Biological Sciences, 14 Science Drive 4, National University of Singapore, 117543, Singapore, Singapore., Ong DST; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117593, Singapore. phsostd@nus.edu.sg.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. phsostd@nus.edu.sg.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. phsostd@nus.edu.sg.; National Neuroscience Institute, 308433, Singapore, Singapore. phsostd@nus.edu.sg.
Publikováno v: Cell death & disease [Cell Death Dis] 2024 May 14; Vol. 15 (5), pp. 338. Date of Electronic Publication: 2024 May 14.
Zobrazit plný text záznamu
5
Akademický článek
Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review.
Autor: Shen Y; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Thng DKH; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Wong ALA; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Toh TB; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore. lsittb@nus.edu.sg.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore. lsittb@nus.edu.sg.
Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2024 Apr 13; Vol. 13 (1), pp. 40. Date of Electronic Publication: 2024 Apr 13.
Zobrazit plný text záznamu
6
Akademický článek
Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy.
Autor: Yi Z; Department of Chemistry, National University of Singapore, Singapore 117543, Singapore.; The N1 Institute for Health, National University of Singapore, Singapore 117456, Singapore., Qin X; Department of Materials Science, Fudan University, Shanghai 200438, P. R. China.; Center for Biotechnology and Biomedical Engineering, Yiwu Research Institute of Fudan University, Yiwu 322000, P. R. China., Zhang L; Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University Cancer Center, Tongji University School of Medicine, Shanghai 200072, P. R. China., Chen H; Center of Super-Diamond and Advanced Films (COSDAF), Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon 999077, Hong Kong SAR, P. R. China., Song T; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China., Luo Z; Department of Chemistry, National University of Singapore, Singapore 117543, Singapore.; The N1 Institute for Health, National University of Singapore, Singapore 117456, Singapore., Wang T; Department of Chemistry, National University of Singapore, Singapore 117543, Singapore., Lau J; Department of Chemistry, National University of Singapore, Singapore 117543, Singapore.; The N1 Institute for Health, National University of Singapore, Singapore 117456, Singapore., Wu Y; Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University Cancer Center, Tongji University School of Medicine, Shanghai 200072, P. R. China., Toh TB; The N1 Institute for Health, National University of Singapore, Singapore 117456, Singapore., Lee CS; Center of Super-Diamond and Advanced Films (COSDAF), Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon 999077, Hong Kong SAR, P. R. China., Bu W; Department of Materials Science, Fudan University, Shanghai 200438, P. R. China.; Center for Biotechnology and Biomedical Engineering, Yiwu Research Institute of Fudan University, Yiwu 322000, P. R. China.; Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University Cancer Center, Tongji University School of Medicine, Shanghai 200072, P. R. China., Liu X; Department of Chemistry, National University of Singapore, Singapore 117543, Singapore.; The N1 Institute for Health, National University of Singapore, Singapore 117456, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Publikováno v: Journal of the American Chemical Society [J Am Chem Soc] 2024 Apr 03; Vol. 146 (13), pp. 9413-9421. Date of Electronic Publication: 2024 Mar 20.
Zobrazit plný text záznamu
7
Akademický článek
A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids.
Autor: Thng DKH; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Hooi L; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Siew BE; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lee KY; Division of Colorectal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore, Singapore., Tan IJ; Division of Colorectal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore, Singapore., Lieske B; Division of Colorectal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore, Singapore., Lin NS; Division of Colorectal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore, Singapore., Kow AWC; Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore, Singapore., Wang S; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Rashid MBMA; Kyan Technologies, Singapore, Singapore., Ang C; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Koh JJM; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Toh TB; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tan KK; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. kerkan@nus.edu.sg.; Division of Colorectal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore, Singapore. kerkan@nus.edu.sg., Chow EK; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. csikce@nus.edu.sg.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. csikce@nus.edu.sg.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore. csikce@nus.edu.sg.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. csikce@nus.edu.sg.; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore. csikce@nus.edu.sg.
Publikováno v: NPJ precision oncology [NPJ Precis Oncol] 2024 Feb 27; Vol. 8 (1), pp. 52. Date of Electronic Publication: 2024 Feb 27.
Zobrazit plný text záznamu
8
Akademický článek
Pazopanib elicits remarkable response in metastatic porocarcinoma: a functional precision medicine approach.
Autor: Chan SPY; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Low CE; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Yau CE; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Lin TP; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology, A*STAR, Singapore., Wang W; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Xiu SX; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Tang PY; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Luo B; The N1 Institute for Health, National University of Singapore, Singapore., Noor NFBM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Lee KA; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore., Chiang J; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Toh TB; The N1 Institute for Health, National University of Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Chow EK; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; The N1 Institute for Health, National University of Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Yang VS; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology, A*STAR, Singapore; yangswv@imcb.a-star.edu.sg.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore.
Publikováno v: Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2024 Jan 10; Vol. 9 (4). Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2023).
Zobrazit plný text záznamu
9
Akademický článek
Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.
Autor: Thng DKH; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Hooi L; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Toh CCM; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Lim JJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Rajagopalan D; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Syariff IQC; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tan ZM; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Rashid MBMA; KYAN Therapeutics, Singapore, Singapore., Zhou L; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Kow AWC; Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Bonney GK; Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Goh BKP; Department of Hepatopancreatobiliary (HPB) and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore., Kam JH; Department of Hepatopancreatobiliary (HPB) and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore., Jha S; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA., Dan YY; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Chow PKH; Department of Hepatopancreatobiliary (HPB) and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore.; Academic Clinical Programme for Surgery, Duke-NUS Medical School, Singapore, Singapore., Toh TB; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Chow EK; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Publikováno v: Molecular oncology [Mol Oncol] 2023 Nov; Vol. 17 (11), pp. 2275-2294. Date of Electronic Publication: 2023 Mar 29.
Zobrazit plný text záznamu
10
Akademický článek
Biomarkers for immune checkpoint inhibition in sarcomas - are we close to clinical implementation?
Autor: Yiong CS; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.; Department of Pharmacy, National University of Singapore, Singapore, 117544, Singapore., Lin TP; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.; Department of Pharmacy, National University of Singapore, Singapore, 117544, Singapore., Lim VY; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Toh TB; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Yang VS; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore. yangswv@imcb.a-star.edu.sg.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore. yangswv@imcb.a-star.edu.sg.; Duke-NUS Medical School, Oncology Academic Clinical Program, Singapore, 169857, Singapore. yangswv@imcb.a-star.edu.sg.
Publikováno v: Biomarker research [Biomark Res] 2023 Aug 23; Vol. 11 (1), pp. 75. Date of Electronic Publication: 2023 Aug 23.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje